Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: Relationships and clinical implications

Endocrine Practice

Volumn 18, Issue 3, 2012, Pages 412-417

  Eldeiry, Leslie S ^a   Ruan, Daniel T ^b   Brown, Edward M ^b   Gaglia, Jason L ^a   Garber, Jeffrey R ^a  

^a HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; PARATHYROID HORMONE;

ADULT; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; ECHOGRAPHY; EXERCISE TOLERANCE; FAMILIAL DISEASE; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; FATIGUE; FEMALE; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOSITY; HISTOLOGY; HUMAN; HYPERCALCEMIA; HYPOCALCIURIA; INCIDENCE; INCIDENTAL FINDING; MALE; MEDICAL HISTORY; OSTEOPENIA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PATIENT CARE; POSTOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM; REVIEW; URINARY EXCRETION; VITAMIN D DEFICIENCY;

FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; MUTATION; PARATHYROIDECTOMY; RECEPTORS, CALCIUM-SENSING; SEVERITY OF ILLNESS INDEX;

EID: 84861039167     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11272.RA     Document Type: Review

References (26)

1. Pollak MR, Brown EM, Chou YH, et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypo-calciuric hypercalcemia and neonatal severe hyperparathy-roidism. Cell. 1993;75:1297-1303.
2. Pearce SH, Trump D, Wooding C, et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest. 1995;96:2683-2692.
3. Calcium-Sensing Receptor Database. Available at: Http://www.casrdb. mcgill.ca. Accessed March 3, 2012.
4. Carling T, Szabo E, Bai M, et al. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cy-toplasmic tail of the calcium receptor. J Clin Endocrinol Metab. 2000;85:2042-2047.
5. Guarnieri V, Canaff L, Yun FH, et al. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: Stud-ies from a single endocrine clinic over three years. J Clin Endocrinol Metab. 2010;95;4:1819-1829.
6. Ho C, Conner DA, Pollak MR, et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet. 1995;11:389-394.
7. Heath H 3rd, Jackson CE, Otterud B, Leppert MF. Genetic linkage analysis in familial benign (hypocalciu-ric) hypercalcemia: Evidence for locus heterogeneity. Am J Hum Genet. 1993;53:193-200.
8. Lloyd SE, Pannett AA, Dixon PH, Whyte MP, Thakker RV. Localization of familial benign hypercalcemia, Okla-homa variant (FBHOk), to chromosome 19q13. Am J Hum Genet. 1999;64:189-195.
9. Bringhurst FR, Demay MB, Kronenberg HM. Hor-mones and Disorders of Mineral Metabolism. In: Kronen-berg HM, Melmed S, Polonsky KS, Larsen PR, eds. Wil-liams Textbook of Endocrinology. 11th edition. Philadel-phia, PA: Saunders-Elsevier, 2008: 1269-1270.
10. Rubin MR, Bilezikian JP, McMahon DJ, et al. The natu-ral history of primary hyperparathyroidism with or with-out parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93:3462-3470.
11. Bilezikian JP, Khan AA, Potts JT Jr; Third Internation-al Workshop on the Management of Asymptomatic Pri-mary Hyperparathyroidism. Guidelines for the manage-ment of asymptomatic primary hyperparathyroidism: Sum-mary statement from the Third International Workshop. J Clin Endocrinol Metab. 2009;94:335-339.
12. Endres DB, Villanueva R, Sharp CF Jr, Singer FR. Im-munochemiluminometric and immunoradiometric deter-minations of intact and total immunoreactive parathyrin: Performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem. 1991;37:162-168.
13. Nissen PH, Christensen SE, Heickendorff L, Brixen K, Mosekilde L. Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: Phenotypic variation and mutation spectrum in a Danish population. J Clin Endocrinol Metab. 2007;92:4373-4379.
14. Christensen SE, Nissen PH, Vestergaard P, Heickend-orff, L, Brixen K, Mosekilde L. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and pri-mary hyperparathyroidism: A follow-up study on methods. Clin Endocrinol (Oxf). 2008;69:713-720.
15. Glendenning P, Stuckey BG. The estimated prevalence of familial hypocalciuric hypercalcemia (FHH). Calcif Tissue Int. 2002;70:512.
16. Law WM Jr, James EM, Charboneau JW, Purnell DC, Heath H 3rd. High-resolution parathyroid ultrasonogra-phy in familial benign hypercalcemia (familial hypocalciu-ric hypercalcemia). Mayo Clin Proc. 1984;59;3:153-155.
17. Thorgeirsson U, Costa J, Marx SJ. The parathyroid glands in familial hypocalciuric hypercalcemia. Hum Pathol. 1981;12:229-237.
18. Law WM Jr, Carney JA, Heath H 3rd. Parathyroid glands in familial benign hypercalcemia (familial hypocal-ciuric hypercalcemia). Am J Med. 1984;76:1021-1026.
19. Rao DS, Honasoge M, Divine GW, et al. Effect of vita-min D nutrition on parathyroid adenoma weight: Pathoge-netic and clinical implications. J Clin Endocrinol Metab. 2000;85:1054-1058.
20. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. The effects of vitamin D insufficiency in patients with pri-mary hyperparathyroidism. Am J Med. 1999;107:561-567.
21. Zajickova K, Vrbikova J, Canaff L, Pawelek PD, Goltzman D, Hendy GN. Identification and functional characterization of a novel mutation in the calcium-sens-ing receptor gene in familial hypocalciuric hypercalcemia: Modulation of clinical severity by vitamin D status. J Clin Endocrinol Metab. 2007;92:2616-2623.
22. Lafferty FW. Differential diagnosis of hypercalcemia. J Bone Miner Res. 1991;6(Suppl 2):S51-S59.
23. Frank-Raue K, Leidig-Bruckner G, Haag C, et al. In-activating calcium-sensing receptor mutations in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf). 2011. doi: 10.1111/j.1365-2265.2011.04059.x. [Epub ahead of print].
24. Burski K, Torjussen B, Paulsen AQ, Boman H, Boller-slev J. Parathyroid adenoma in a subject with familial hy-pocalciuric hypercalcemia: Coincidence or causality? J Clin Endocrinol Metab. 2002;87:1015-1016.
25. Yabuta T, Miyauchi A, Inoue H, Yoshida H, Hirokawa M, Amino N. A patient with primary hyperparathyroidism associated with familial hypocalciuric hypercalcemia in-duced by a novel germline CaSR gene mutation. Asian J Surg. 2009;32:118-122.
26. Brachet C, Boros E, Tenoutasse S, et al. Association of parathyroid adenoma and familial hypocalciuric hypercal-caemia in a teenager. Eur J Endocrinol. 2009;161:207-210.